Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep-sea fish oil for prevention of acute radiation-induced esophagitis
NCT06392971Phase 2Recruiting
- Sponsor
- The First Affiliated Hospital of Chengdu Medical College
- Start
- Jan 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in radiation esophagitis comparing Deep-sea fish oil with Placebo (2 arms). Primary endpoints: The duration from initiation of radiotherapy to the onset of acute radiation esophagitis at 2 months, Severity of acute radiation esophagitis at 2 months and 1 more. Started Jan 2023; status: recruiting.
02
Drugs
omega-3-acid triglycerides
03
Conditions
radiation esophagitis
Beyond the preview
Go deeper on NCT06392971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06392971.